BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 11456356)

  • 1. Clostridium bacteremia: emphasis on the poor prognosis in cirrhotic patients.
    Chen YM; Lee HC; Chang CM; Chuang YC; Ko WC
    J Microbiol Immunol Infect; 2001 Jun; 34(2):113-8. PubMed ID: 11456356
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical features and therapeutic implications of 104 episodes of monomicrobial Aeromonas bacteraemia.
    Ko WC; Lee HC; Chuang YC; Liu CC; Wu JJ
    J Infect; 2000 May; 40(3):267-73. PubMed ID: 10908022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short-term prognosis of community-acquired bacteremia in patients with liver cirrhosis or alcoholism: A population-based cohort study.
    Linderoth G; Jepsen P; Schønheyder HC; Johnsen SP; Sørensen HT
    Alcohol Clin Exp Res; 2006 Apr; 30(4):636-41. PubMed ID: 16573581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of Clostridium species bacteremia in Calgary, Canada, 2000-2006.
    Leal J; Gregson DB; Ross T; Church DL; Laupland KB
    J Infect; 2008 Sep; 57(3):198-203. PubMed ID: 18672296
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for mortality of bacteremic patients in the emergency department.
    Lin JN; Tsai YS; Lai CH; Chen YH; Tsai SS; Lin HL; Huang CK; Lin HH
    Acad Emerg Med; 2009 Aug; 16(8):749-55. PubMed ID: 19594458
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-O1 Vibrio cholerae bacteremia in patients with cirrhosis: 5-yr experience from a single medical center.
    Lin CJ; Chiu CT; Lin DY; Sheen IS; Lien JM
    Am J Gastroenterol; 1996 Feb; 91(2):336-40. PubMed ID: 8607503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of liver cirrhosis on mortality in patients with community-acquired bacteremia.
    Chen SY; Tsai CL; Lin CH; Lee CC; Chiang WC; Wang JL; Ma MH; Chen SC; Chen WJ; Chang SC
    Diagn Microbiol Infect Dis; 2009 Jun; 64(2):124-30. PubMed ID: 19304439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Community-acquired anaerobic bacteremia in adults: one-year experience in a medical center.
    Hung MN; Chen SY; Wang JL; Chang SC; Hsueh PR; Liao CH; Chen YC
    J Microbiol Immunol Infect; 2005 Dec; 38(6):436-43. PubMed ID: 16341345
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical characteristics and outcomes of pneumococcal bacteremia in adult patients with liver cirrhosis.
    Choi SH; Park HG; Jun JB; Lee SO; Choi SH; Woo JH; Kim YS
    Diagn Microbiol Infect Dis; 2009 Feb; 63(2):160-4. PubMed ID: 19150708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical significance of and outcomes for Bacteroides fragilis bacteremia.
    Cheng CW; Lin HS; Ye JJ; Yang CC; Chiang PC; Wu TS; Lee MH
    J Microbiol Immunol Infect; 2009 Jun; 42(3):243-50. PubMed ID: 19812858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clostridial sepsis and malignant disease.
    Tanabe KK; Jones WG; Barie PS
    Surg Gynecol Obstet; 1989 Nov; 169(5):423-8. PubMed ID: 2814753
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outcomes of Aeromonas bacteremia in patients with different types of underlying disease.
    Lau SM; Peng MY; Chang FY
    J Microbiol Immunol Infect; 2000 Dec; 33(4):241-7. PubMed ID: 11269369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serratia marcescens bacteremia at a medical center in southern Taiwan: high prevalence of cefotaxime resistance.
    Shih HI; Lee HC; Lee NY; Chang CM; Wu CJ; Wang LR; Ko NY; Ko WC
    J Microbiol Immunol Infect; 2005 Oct; 38(5):350-7. PubMed ID: 16211144
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Bacteremia caused by anaerobes: analysis of 131 episodes].
    Ramos JM; García-Corbeira P; Fernández-Roblas R; Soriano F
    Enferm Infecc Microbiol Clin; 1994 Jan; 12(1):9-16. PubMed ID: 8155764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clostridium perfringens bacteremia. Opportunist or killer?
    Nelson RM; Wilson RF; Osmer RL
    Am Surg; 1985 Jun; 51(6):301-3. PubMed ID: 2859823
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical characteristics and risk factors for attributable mortality in Enterobacter cloacae bacteremia.
    Lin YC; Chen TL; Ju HL; Chen HS; Wang FD; Yu KW; Liu CY
    J Microbiol Immunol Infect; 2006 Feb; 39(1):67-72. PubMed ID: 16440126
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Prognostic factors of bacteremia: prospective study].
    Pazos Añón R; Fernández Rodríguez R; Paz Vidal I; Tinajas A; Cantón I; Abel V; González R; Martínez R; Gayoso P; Fernández Alvarez O
    An Med Interna; 2001 Aug; 18(8):415-20. PubMed ID: 11589079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of prognostic and risk factors for mortality in polymicrobial bacteremia-fungemia in a university hospital: development over 10 years].
    Ruiz-Giardín JM; Noguerado A; Pizarro A; Méndez J; La Hulla F; Fernández M; Hernández F; San Martín JV; Hernández I; Alvarez J; Salvanes F
    Enferm Infecc Microbiol Clin; 2002 Nov; 20(9):435-42. PubMed ID: 12425877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical characteristics and risk factors for mortality in Morganella morganii bacteremia.
    Lee IK; Liu JW
    J Microbiol Immunol Infect; 2006 Aug; 39(4):328-34. PubMed ID: 16926980
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Group A streptococcal bacteremia: outcome and prognostic factors.
    Vallalta Morales M; Soriano Navarro CJ; Salavert Lletí M; Montero Alonso M; Pérez Bellés C; López Aldeguer J; Otero MC; Gobernado Serrano M
    Rev Esp Quimioter; 2006 Dec; 19(4):367-75. PubMed ID: 17235407
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.